Attached are four filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. Attachments Managers' Transaction Notifications - Ann Merchant(20230621) Managers' Transaction Notifications - Linda

The Annual and Extraordinary General Meeting (the "2023 AGM") of Alvotech (the "Company") was held on June 6, 2023 at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, Grand Duchy of Luxembourg.  Here are the main results of the 2023 AGM. The 2023 AGM approved the Company’s annual

The Annual General Meeting of Alvotech (the “Company”) resolved on June 6, 2023 to grant to certain members of the board a total of 109,524 shares through stock option agreements. The stock options will be granted to four independent board members. The aim of the stock option agreements is to align

Information related the press release issued on May 24, 2023 by Alvotech and Advanz Pharma with the heading "Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe". Entry into Agreements with Advanz On May 22, 2023, Alvotech entered into a